Early & late cerebrovascular biomarkers: Operationalization of cut‐points and temporal progression

Abstract

Background: Cerebrovascular disease (CeVD), a common co‐pathology with Alzheimer's Disease, has not been sufficiently operationalized, limiting its usage for accurate estimation of vascular contributions to cognitive impairment (VCI).